Fan et al. found that CLR displayed higher predicted accuracy of poor prognosis compared to the combination of NLR, platelet to lymphocyte ratio (PLR), C-reactive protein to albumin ratio (CAR), neutrophil to albumin ratio (NAR), and platelet to albumin ratio (PAR) in patients with pancreatic cancer [30]. The gene discussed is ALB; the disease is familial pancreatic carcinoma.